Temple Health and Fox Chase Cancer Center Surgeon Dr. Jay Simhan Receives First-Place Award at Annual Jackson Hole Seminar Series in Urology

Thumbnail
Jay Simhan, MD, FACS, Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University, and Director of Reconstruction at Fox Chase Cancer Center.

PHILADELPHIA (March 12, 2025) — Jay Simhan, MD, FACS, Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University, and Director of Reconstruction at Fox Chase Cancer Center, was recently awarded first place at the 44th Annual Ralph E. Hopkins Jackson Hole Seminar Series in Urology.

“It is a privilege to present my work to such a renowned group of urologic specialists, and I am honored to receive this award,” said Simhan. “The Jackson Hole Seminar Series uniquely blends friendly competition and collaboration, allowing top urologic specialists to exchange knowledge and advance the field. I am thrilled that my work has made an impact on my peers across urologic subspecialties.”

Simhan is one of the few reconstructive urologists with an active practice encompassing urethral reconstruction, prosthetic surgery — including artificial urinary sphincter and inflatable penile prosthesis — and complex abdominal reconstruction. His award-winning presentations spanned these diverse subject areas, demonstrating not only clinical expertise but also significant contributions to research in these fields. His five presentations at the seminar were grounded in his published work, reinforcing his role as a thought leader in reconstructive and prosthetic urology.

The Jackson Hole Seminar series convenes leading experts in urology to present on a wide range of topics. Following the seminar, a panel of distinguished judges selects top speakers for recognition at a banquet ceremony. Simhan earned the first-place award after presenting to an audience of noted urologic specialists, board members, judges, and previous faculty members.

The 2025 critique panel included professors and department chairs from institutions such as New York Presbyterian Hospital/Weill Cornell Medical Center, Brigham & Women’s Hospital, Harvard Medical School, Johns Hopkins University School of Medicine, and Prisma Health — University of South Carolina School of Medicine.

Simhan specializes in complications from urologic cancer treatment, urethral stricture disease, penile implant surgery, male anti-incontinence surgery, and Peyronie’s disease, as well as open and robotic urinary tract reconstruction, genitourinary trauma/injury, and revision male urologic prosthetic surgery.

Simhan earned his medical degree from the University of North Carolina at Chapel Hill before completing general surgery and urology residencies at Temple University Hospital and Fox Chase Cancer Center. He then pursued fellowship training in urologic trauma, reconstruction, and prosthetics at the University of Texas Southwestern in Dallas.

A dedicated leader in the field, Simhan is actively involved in multiple professional organizations, including the American Urologic Association, the American College of Surgeons, the Society of Genitourinary Reconstructive Surgeons (GURS), Société Internationale d’Urologie, the Society of Urologic Prosthetic Surgeons, and the Sexual Medicine Society of North America. He currently serves as Fellowship Committee Chair and a Board Member of GURS, where he oversees global fellowship programs in reconstructive urology. 

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427